822 articles
Patrick Y. Wen
Patrick Y. Wen, also known as Patrick Wen, is a neuro-oncologist who directs the Neuro-Oncology Division at Brigham and Women's Hospital and is Professor of Neurology at Harvard Medical School.
Paul Aisen
Paul S. Aisen is a neurologist and Alzheimer's disease researcher who directs the USC Alzheimer's Therapeutic Research Institute and the Alzheimer's Clinical Trials Consortium, after leading the Alzheimer's Disease Cooperative Study.
Paul Flechsig
Paul Emil Flechsig (1847–1929) was a German neuroanatomist and psychiatrist who held the first psychiatry chair at Leipzig and founded the myelogenetic method of cortical mapping.
Paul Harrison (psychiatrist)
Paul J. Harrison (born 1960) is a British psychiatrist and neuroscientist, Professor of Psychiatry at Oxford since 2000, known for research on schizophrenia, bipolar disorder, and COVID-19.
Paul Ivan Yakovlev
Paul Ivan Yakovlev (1894–1983) was a Russian-born American neuroanatomist, Clinical Professor of Neuropathology at Harvard Medical School and founder of a collection of nearly 1,000 brain specimens.
Paul M. Matthews
Paul M. Matthews is a neurologist who founded Oxford's FMRIB brain imaging center, worked in imaging research at GlaxoSmithKline, and studies neuroinflammation in Alzheimer's disease and multiple sclerosis.
Paul M. Thompson
Paul M. Thompson is a neuroscientist and professor at the University of Southern California who co-founded the ENIGMA Consortium, a worldwide alliance of brain-imaging scientists studying brain diseases.
Paul O’Connor
Paul W. O'Connor is a Canadian neurologist and clinical epidemiologist who led pivotal multiple sclerosis trials, including the 2003 natalizumab and 2011 TEMSO teriflunomide trials.
Paul Robert Bing
Paul Robert Bing (1878–1956) was a German-Swiss neurologist who founded modern neurology in Basel, wrote influential neurology textbooks, and gave his name to Bing's reflex and the Bing-Horton syndrome.
Paul S. Appelbaum
Paul S. Appelbaum is an American psychiatrist at Columbia University who works at the intersection of law, ethics, and psychiatry, known for the MacCAT-T capacity assessment tool.
Paul Sandifer
Paul Harmer Sandifer (1908–1964) was a British neurologist remembered as the pioneer of British pediatric neurology and for Sandifer syndrome, a reflux-related dystonia of childhood.
Per Soelberg Sørensen
Per Soelberg Sørensen is a Danish neurologist and multiple sclerosis researcher who founded the Danish Multiple Sclerosis Center at Rigshospitalet and won the 2017 Charcot award.
Per Svenningsson
Per Svenningsson is a Swedish neurologist and neuroscientist, Professor of Neurology at Karolinska Institutet and a Senior Physician at Karolinska University Hospital, known for work on serotonin signaling and Parkinson's disease.
Perry F. Renshaw
Perry F. Renshaw is an American physician-scientist in psychiatric neuroimaging who led McLean Hospital's Brain Imaging Center from 1992 to 2008 and studies brain chemistry in mood disorders.
Peter A. Calabresi
Peter A. Calabresi is an American neurologist and neuroimmunologist known for research on how immune cells damage the brain in multiple sclerosis and for retinal imaging to track the disease.
Peter Goadsby
Peter J. Goadsby is an Australian-born neurologist and headache researcher at King's College London whose CGRP work led to new migraine drugs; he shared the 2021 Brain Prize.
Peter J. Hutchinson
Peter J. Hutchinson is a British neurosurgeon and NIHR Research Professor at the University of Cambridge, known for leading the RESCUE trials on traumatic brain injury.
Peter Langhorne
Peter Langhorne is a physician and stroke researcher at the University of Glasgow, professor of stroke care from 2001 to 2020, who founded the Stroke Unit Trialists' Collaboration.
Peter McL. Black
Peter McL. Black, also known as Peter M. Black, is a Canadian-born neurosurgeon and brain tumor researcher who is Franc D. Ingraham Professor of Neurosurgery, Emeritus, at Harvard.
Peter Rothwell
Peter M. Rothwell is a British clinical neurologist and Professor of Clinical Neurology at the University of Oxford, known for stroke prevention research and the EXPRESS study.
Peter Sandercock
Peter Sandercock is a neurologist and Emeritus Professor of Medical Neurology at the University of Edinburgh who led the International Stroke Trial and its successor, IST-3.
Peter T. Lansbury
Peter T. Lansbury, also known as Peter Lansbury, is an American chemist turned neurodegeneration researcher, professor of neurology at Harvard Medical School, and founder of Link Medicine.
Peter Tyrer
Peter Tyrer is a British community psychiatrist, Emeritus Professor at Imperial College London, who chaired the WHO group revising personality disorder classification for ICD-11 and developed nidotherapy.
Peter W. Lampert
Peter W. Lampert (1929–1986) was a German-born American neuropathologist who chaired pathology at UCSD from 1979 until his death, using electron microscopy to study demyelination and viral disease.
Philip A. Wolf
Philip A. Wolf is an American neurologist and epidemiologist who joined the Framingham Heart Study in 1967 as its first neurologist and served as principal investigator from 1989 to 2014.
Philip C. Wong
Philip C. Wong is a professor of pathology and neuroscience at Johns Hopkins School of Medicine whose laboratory studies TDP-43 in Alzheimer's disease and ALS-FTD, including a 2024 presymptomatic fluid biomarker.
Philip J. Cowen
Philip J. Cowen is a psychiatrist and Professor of Psychopharmacology at the University of Oxford whose 1997 Lancet tryptophan-depletion study showed how serotonin relates to depressive relapse.
Philip McGuire
Philip McGuire is a British psychiatrist and Professor of Psychiatry at the University of Oxford, known for brain imaging and clinical trial research on schizophrenia and psychosis.
Philip R. Dodge
Philip R. Dodge (1923–2009) was an American pediatric neurologist, remembered as a founder of pediatric neurology, who established Mass General's pediatric neurology department in 1956.
Philip Scheltens
Philip Scheltens is a Dutch neurologist and Alzheimer's researcher, emeritus professor at Amsterdam UMC, founder of its Alzheimer Center, and now head of the Dementia Fund at EQT Life Sciences.